Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study
- 29 April 2003
- journal article
- clinical trial
- Published by Elsevier in Antiviral Research
- Vol. 59 (1) , 49-56
- https://doi.org/10.1016/s0166-3542(03)00065-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Postherpetic Neuralgia: Impact of Famciclovir, Age, Rash Severity, and Acute Pain in Herpes Zoster PatientsThe Journal of Infectious Diseases, 1998
- The clinical course of herpes zoster: A prospective study in primary careThe European Journal of General Practice, 1996
- Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adultsAntimicrobial Agents and Chemotherapy, 1995
- Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patientsInternational Journal of Antimicrobial Agents, 1994
- Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2′-deoxyuridineZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Antivirals for the treatment of herpesvirus infectionsJournal of Antimicrobial Chemotherapy, 1993
- Epidemiology of ShinglesJournal of the Royal Society of Medicine, 1990
- The antiviral spectrum of (E)-5-(2-bromovinyl)-2 '-deoxyuridineJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics of acyclovir after intravenous and oral administrationJournal of Antimicrobial Chemotherapy, 1983